Stay updated with breaking news from 68554v10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OraSure Technologies, Inc. (NASDAQ:OSUR – Get Rating) has received an average rating of “Hold” from the six research firms that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price objective among […]
OraSure Technologies (NASDAQ:OSUR – Get Rating) and Sigyn Therapeutics (NASDAQ:SIGY – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings. Volatility and Risk OraSure Technologies has a beta of […]
Comerica Bank cut its holdings in shares of OraSure Technologies, Inc. (NASDAQ:OSUR – Get Rating) by 3.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 65,451 shares of the medical instruments supplier’s stock after selling 2,070 shares during the quarter. Comerica Bank’s holdings in […]
OraSure Technologies (NASDAQ:OSUR – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks, “OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other […]